SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-042119
Filing Date
2012-08-16
Accepted
2012-08-16 14:31:00
Documents
1
Period of Report
2012-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3097
  Complete submission text file 0001209191-12-042119.txt   4422
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address
Business Address
GOLDSTEIN JACK (Reporting) CIK: 0001230729 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 121039645